NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Shares Outstanding (2010 - 2026)

NextPlat's (NXPL) quarterly Shares Outstanding (Entity) came in at $2.7 million in Q2 2026, up 4.5% year-over-year from $2.6 million in Q2 2025, and little changed quarter-over-quarter from $2.7 million in Q1 2026.

Analysis

NextPlat (NXPL) Shares Outstanding (2010 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Shares Outstanding (Entity) for 17 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Shares Outstanding (Entity) rose 4.5% year-over-year to $2.7 million in Q2 2026; TTM through Jun 2026 was $2.7 million, a 4.5% increase from a year earlier, with the FY2025 full-year figure at $2.7 million, up 29.85% from the prior year.
  • Shares Outstanding (Entity) was $2.7 million for Q2 2026 at NextPlat, roughly flat from $2.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $2.7 million in Q2 2026 and troughed at $929310.0 in Q1 2022.
  • A 5-year average of $1.9 million and a median of $1.9 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • Across the five-year window, Shares Outstanding (Entity) jumped 843.23% in 2022 and increased 1.43% in 2024, its largest moves.
  • Over 5 years, Shares Outstanding (Entity) stood at $962959.0 in 2022, then soared by 94.45% to $1.9 million in 2023, then gained by 10.09% to $2.1 million in 2024, then climbed by 29.85% to $2.7 million in 2025, then increased by 1.36% to $2.7 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $2.7 million (Q2 2026), $2.7 million (Q1 2026), and $2.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 1.17 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 1.16 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 832.44 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 319.20 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 375.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 21.16 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 289.73 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 43.64 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 34.55 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 2.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.71 Mn
Mar 31, 2026 2.69 Mn
Dec 31, 2025 2.65 Mn
Sep 30, 2025 2.60 Mn
Jun 30, 2025 2.60 Mn
Mar 31, 2025 2.60 Mn
Dec 31, 2024 2.06 Mn
Sep 30, 2024 1.90 Mn
Jun 30, 2024 1.88 Mn
Mar 31, 2024 1.87 Mn
Dec 31, 2023 1.75 Mn
Sep 30, 2023 1.87 Mn
Jun 30, 2023 1.81 Mn
Mar 31, 2023 1.44 Mn
Dec 31, 2022 962,959.00
Sep 30, 2022 946,951.00
Jun 30, 2022 929,310.00
Mar 31, 2022 916,688.00
Dec 31, 2021 408,083.00
Sep 30, 2021 629,031.00